Published on in CHOP News
CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.
Published on in CHOP News
CHOP researchers have shown that two kinases are essential in melanosome biogenesis, and that these kinases localize sequentially.
Published on in CHOP News
CHOP researchers have revealed the molecular mechanics of a cell-surface molecule that is a potential immunotherapy target.
Published on in CHOP News
CHOP researchers have developed new software called CancerVar, which helps researchers assess the clinical impacts of over 13 million somatic cancer mutations.
Published on in CHOP News
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.
Published on in CHOP News
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.
Published on in CHOP News
CHOP researchers have found no detectable levels of double-stranded RNA during adenovirus infection, upending previous assumptions about infection by the virus.
Published on in CHOP News
Their projects will focus on different aspects of gene expression, from developing new imaging tools to searching for causes of cancer.
Published on in CHOP News
Dr. Stephen R. Master will serve as president of the American Association for Clinical Chemistry until July 2022.
Published on in CHOP News
Type II alveolar cells, a major cell type infected by SARS-CoV-2, possess unique immunologic properties and appear to play a role in improving the outcome of respiratory viral infections.